Cargando…
MSC-EV therapy for bone/cartilage diseases
Mesenchymal stromal cells (MSCs) have been utilized in cell therapy for various diseases. Recent studies have demonstrated that extracellular vesicles (EVs) released by MSCs play an important role in their therapeutic activities. EVs contain a variety of bioactive molecules such as proteins, messeng...
Autores principales: | Kodama, Joe, Wilkinson, Kevin J., Otsuru, Satoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663871/ https://www.ncbi.nlm.nih.gov/pubmed/36389627 http://dx.doi.org/10.1016/j.bonr.2022.101636 |
Ejemplares similares
-
The role of hypertrophic chondrocytes in regulation of the cartilage-to-bone transition in fracture healing
por: Kodama, Joe, et al.
Publicado: (2022) -
Novel insights into MSC-EVs therapy for immune diseases
por: Lai, Peilong, et al.
Publicado: (2019) -
Nutrient metabolism of the nucleus pulposus: A literature review
por: Kodama, Joe, et al.
Publicado: (2022) -
Micro RNA based MSC EV engineering: Targeting the BMP2 cascade for bone repair
por: Huang, Chun-Chieh, et al.
Publicado: (2023) -
Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by (18)F-fluoride positron emission tomography
por: Bruijnen, Stefan T G, et al.
Publicado: (2018)